Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion type Assertion NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_head.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion evidence source_evidence_literature NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion SIO_000772 20810575 NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion wasDerivedFrom befree-20150227 NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion wasGeneratedBy ECO_0000203 NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.